CacheBy
Thermo Fisher Scientific Human CENPO Synthetic Peptide
원본

Thermo Fisher Scientific Human CENPO Synthetic Peptide

상품 한눈에 보기

인간 CENPO 단백질의 중심부 16개 아미노산 서열로 구성된 합성 펩타이드. PA5-20826 항체의 블로킹 펩타이드로 사용 가능. 액상 형태로 제공되며 PBS 버퍼에 0.1% BSA와 0.02% sodium azide 포함. -20°C에서 보관.

카탈로그번호
PEP0940
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 03. 오후 04:31
Thermo Fisher Scientific PEP0940 Human CENPO Synthetic Peptide 50 ug pk판매 단위 pk ·
재고 확인 필요
195,500원VAT 포함 215,050원

Thermo Fisher Scientific · Thermo Fisher Scientific Human CENPO Synthetic Peptide

Applications

Control (Ctrl)

  • Assay-dependent

Blocking Assay (BLOCK)

  • Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Class Synthetic
Type Peptide
Conjugate Unconjugated
Form Liquid
Concentration 200 µg/mL
Purification Purified
Storage buffer PBS, pH 7.2, with 0.1% BSA
Contains 0.02% sodium azide
Storage conditions -20°C

Product Specific Information

This peptide corresponds to 16 amino acids near the center of human CENPO.
PEP-0940 can be used as a blocking peptide with polyclonal antibody PA5-20826.

Target Information

Accurate chromosome segregation during mitosis requires a kinetochore to assemble correctly at the centromere of each chromatid and form a dynamic interface with the microtubules of the mitotic spindle. The kinetochore assembly includes the multisubunit CENP-H/I complex which can be divided into three functional classes based on phenotype analysis. One of these classes is referred to as the CENP-O class of proteins of which CENPO is the exemplar. These proteins form a stable complex with each other and are required for proper kinetochore function and for recovery from mitotic spindle damage. CENPO has also been shown to be an auto-antigen in a small population of anti-centromere antibodies (ACA) positive patients with scleroderma.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.